Cargando…

No evidence of adverse neurological outcomes from COVID-19 vaccines

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Unknown
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990639/ http://dx.doi.org/10.1007/s40278-022-12687-0

Ejemplares similares

Factors affecting COVID-19 vaccine acceptability in the US
Publicado: (2020)

FDA limits authorised use of Janssen COVID-19 vaccine
Publicado: (2022)

Thrombocytopenic purpura with AstraZeneca but not Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021)

Pfizer COVID-19 vaccine recommended for pregnant women in Australia and New Zealand
Publicado: (2021)

UK's NICE issues guideline on diagnosing rare COVID-19 vaccination-related blood clots
Publicado: (2021)

ICER releases pricing models for potential COVID-19 treatments
Publicado: (2020)

COVID-19 lockdown increased diabetic mortality, morbidity and costs in Italy
Publicado: (2021)

Pre-COVID-19 psychotropic medication use linked to higher rate of dementia
Publicado: (2022)

UK's NICE updates COVID-19 guideline to include monoclonal antibody recommendations
Publicado: (2021)

International Society of Pharmacovigilance monitors vaccine safety
Publicado: (2022)

Revision of Comirnaty precautions in Japan
Publicado: (2022)

SMC approves nine new medicines for NHS Scotland
Publicado: (2020)

Worldwide HTA access to ICER's cost-effectiveness models
Publicado: (2020)

Global health spending set to grow, but remain unequally distributed between countries
Publicado: (2021)

New NICE strategy aims to provide quicker access to new healthcare
Publicado: (2021)

Global medicine spending set to reach $US1.6 trillion by 2025
Publicado: (2021)

Termination of tachycardia with resolution of left bundle branch block: What is the mechanism?
por: Oesterle, Adam, et al.
Publicado: (2018)

Circular mapping recordings in a persistent left superior vena cava during atrial tachycardia: Was isolation achieved?
por: Venier, Sandrine, et al.
Publicado: (2015)

Repeat inappropriate defibrillator discharges following defibrillator implantation. What is the mechanism and treatment?
por: Docekal, Jeremy W., et al.
Publicado: (2016)

Vibratory alert in a recalled implantable cardioverter-defibrillator: Is there something wrong with the device?
por: Ortman, Matthew
Publicado: (2017)

Minimally preexcited tachycardia: What is the mechanism?
por: Nagashima, Koichi, et al.
Publicado: (2020)

A short RP tachycardia with alternating ventriculoatrial interval, but identical atrial activation sequence: What is the mechanism?
por: Egami, Yasuyuki, et al.
Publicado: (2020)

Unmasking of triple atrial potentials in the coronary sinus during orthodromic reciprocating tachycardia: What is the mechanism?
por: Morishima, Itsuro, et al.
Publicado: (2020)

Resolution of right bundle branch block after a premature ventricular beat: What is the mechanism?
por: Hillyard, Jonathan, et al.
Publicado: (2019)

Implantable cardioverter-defibrillator shocks due to tachycardia with more atrial depolarizations than ventricular depolarizations with a far-field ventricular morphology shift: What is the mechanism?
por: Zhang, Xin, et al.
Publicado: (2020)

Hyperkalemia-induced escape capture bigeminy
por: Reddy Manne, Janaki Rami, et al.
Publicado: (2021)

Repetitive loss of accessory pathway conduction: What is the mechanism?
por: Tan, Eugene S.J., et al.
Publicado: (2021)

Wide and narrow QRS complexes during flutter. What’s the mechanism?
por: Răileanu, Gabriela, et al.
Publicado: (2021)

Long and longer retrograde conduction. What is the solution?
por: Klop, Boudewijn, et al.
Publicado: (2021)

Multiple exit sites identification by pace mapping with a grid catheter: Which bipolar pairs are in the critical ventricular tachycardia isthmus?
por: Itoh, Taihei, et al.
Publicado: (2021)

A regularly irregular wide QRS tachycardia: What is the mechanism?
por: Tampakis, Konstantinos, et al.
Publicado: (2023)

DUFs: families in search of function
por: Bateman, Alex, et al.
Publicado: (2010)

Structure of the first representative of Pfam family PF09410 (DUF2006) reveals a structural signature of the calycin superfamily that suggests a role in lipid metabolism
por: Chiu, Hsiu-Ju, et al.
Publicado: (2009)

The structure of SSO2064, the first representative of Pfam family PF01796, reveals a novel two-domain zinc-ribbon OB-fold architecture with a potential acyl-CoA-binding role
por: Krishna, S. Sri, et al.
Publicado: (2010)

Structure of the first representative of Pfam family PF04016 (DUF364) reveals enolase and Rossmann-like folds that combine to form a unique active site with a possible role in heavy-metal chelation
por: Miller, Mitchell D., et al.
Publicado: (2010)

The structure of the first representative of Pfam family PF09836 reveals a two-domain organization and suggests involvement in transcriptional regulation
por: Das, Debanu, et al.
Publicado: (2009)

Structures of the first representatives of Pfam family PF06684 (DUF1185) reveal a novel variant of the Bacillus chorismate mutase fold and suggest a role in amino-acid metabolism
por: Bakolitsa, Constantina, et al.
Publicado: (2010)

Neurological Adverse Events Associated with COVID-19 Vaccination
por: Jadali, Zohreh
Publicado: (2023)

A review of the potential neurological adverse events of COVID-19 vaccines
por: Mohseni Afshar, Zeinab, et al.
Publicado: (2022)

Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines
por: Dutta, Siddhartha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2g4bn3oeq46895ipllv9nhejhs